Quanticel Pharmaceuticals partners with Celgene to discover cancer biomarkers for Celgene's investigational products

Quanticel Pharmaceuticals Inc.

U.S. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Celgene Corp.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

$28,291.7m on 11/04/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced